Veracyte | VCYT - Pre Tax Profit


Veracyte reported $40.63M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Agenus USD -10.61M 263.52M Dec/2025
Agilent USD 442M 1000K Sep/2025
Anika Therapeutics USD 764K 3M Dec/2025
Arrowhead Research USD 28.27M 7.85M Dec/2025
Bruker USD -72.6M 73.1M Sep/2025
Heron Therapeutics USD -2.95M 14.54M Dec/2025
Illumina USD 220M 86M Sep/2025
Intrexon USD -60.48M 27.09M Jun/2024
Karyopharm Therapeutics USD -39.9M 9.01M Dec/2025
Laboratory Of America USD 337M 32.3M Sep/2025
Ligand Pharmaceuticals USD 141.14M 102M Sep/2025
Myriad Genetics USD 4.6M 3.4M Dec/2025
Rigel Pharmaceuticals USD -1.03M 7.22M Jun/2024
Roche Holding CHF 4.79B 3.01B Jun/2025
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Siemens EUR 2.39B 505M Sep/2025
Sonic Healthcare AUD 402.01M 53.16M Jun/2025
Thermo Fisher Scientific USD 2.12B 295M Dec/2025
Veracyte USD 40.63M 21.74M Dec/2025
Waters USD 170.12M 7.57M Sep/2025